| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/29/1994 | WO1994021241A1 New use of anti-acne agents |
| 09/29/1994 | WO1994021240A2 Superparamagnetic particles, process for producing the same and their use |
| 09/29/1994 | WO1994021235A1 Enhanced circulation effector composition and method |
| 09/29/1994 | WO1994021232A1 Water dispersible therapeutic compounds |
| 09/29/1994 | WO1994021231A1 Therapeutic agent for the treatment of melanomas |
| 09/29/1994 | WO1994021229A1 Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
| 09/29/1994 | WO1994021225A1 Skin care composition |
| 09/29/1994 | WO1994021220A1 Deodorant active-substance combinations made from wool-grease acids and partial glycerides |
| 09/29/1994 | WO1994021117A1 Method and apparatus for encapsulation of biologically-active substances in cells |
| 09/29/1994 | WO1994021115A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 09/29/1994 | WO1994015958A3 Peptide inhibitors of cell adhesion |
| 09/29/1994 | WO1994014833A3 Substituted 6-azaandrostenones |
| 09/29/1994 | WO1994012880A3 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 09/29/1994 | WO1994011490A3 Products of the inhibition of advanced glycosylation |
| 09/29/1994 | WO1994011387A3 A process for the production of finasteride |
| 09/29/1994 | DE4410470A1 Pharmazeutische Zusammensetzungen mit analgetischer Aktivität Pharmaceutical compositions having analgesic activity |
| 09/29/1994 | DE4310076A1 Suspension formulations |
| 09/29/1994 | CA2159085A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 09/29/1994 | CA2158994A1 Heterocycle-containing amidine derivatives, their preparation and use |
| 09/29/1994 | CA2158551A1 Drugs for the treatment of retrovirus infections |
| 09/29/1994 | CA2158545A1 [1,2,4,]triazolo[4,3-a]quinaxoline derivatives, their preparation and use |
| 09/29/1994 | CA2158437A1 Aluminium containing pharmaceutical preparation with controlled release |
| 09/29/1994 | CA2158368A1 Use of substituted alkyl nitrates for the treatment of pathologically raised intraocular pressure |
| 09/29/1994 | CA2158352A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 09/29/1994 | CA2158252A1 Delivery system controlled through factors associated with hiv and cell |
| 09/29/1994 | CA2156839A1 Indazole derivatives |
| 09/29/1994 | CA2156838A1 Antipsychotic indazole derivatives |
| 09/29/1994 | CA2156836A1 Benzimidazole derivatives |
| 09/29/1994 | CA2156741A1 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
| 09/29/1994 | CA2156068A1 Macrocyclic carbamate immunomodulators |
| 09/29/1994 | CA2156067A1 Heterocycle-containing macrocyclic immunomodulators |
| 09/29/1994 | CA2156065A1 Macrocyclic amide and urea immunomodulators |
| 09/29/1994 | CA2156064A1 Substituted alicyclic amine-containing macrocyclic immunomodulators |
| 09/29/1994 | CA2155842A1 Novel heterocycles, their preparation and their use |
| 09/29/1994 | CA2155573A1 Process for production of an imidazole derivative |
| 09/29/1994 | CA2136531A1 Heparan sulphate oligosaccharides having hepatocyte growth factor binding affinity |
| 09/29/1994 | CA2135921A1 Nitic 1,2-benzo-isothiazolyl-3(2h)one-1, 1-dioxide esters, preparation method therefor and drugs containing same |
| 09/28/1994 | EP0617043A1 Platinum compound and process of preparing same |
| 09/28/1994 | EP0617038A1 Preparation of carbonic anhydrase inhibitors |
| 09/28/1994 | EP0617037A1 Enantioselective synthesis of thieno(2,3-b) thiopyran-7, 7-dioxide compounds |
| 09/28/1994 | EP0617036A2 Novel 2-thiosubstituted carbapenems |
| 09/28/1994 | EP0617035A1 Heterotricyclic substituted phenylcyclohexanecarboxylic acid derivatives |
| 09/28/1994 | EP0617034A1 2-Debenzoyl-2-acyl taxol derivatives and methods for making same |
| 09/28/1994 | EP0617032A1 Cyanomethylpyridine derivatives as PAF antagonists and 5-lipoxygenase inhibitors |
| 09/28/1994 | EP0617031A1 Orally active azole derivates |
| 09/28/1994 | EP0617030A1 Sulfonate and carbamate derivatives of 3-aroylbenzo (beta) thiophenes |
| 09/28/1994 | EP0617028A1 Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulfonyl piperazine |
| 09/28/1994 | EP0617027A1 N-Benzylpiperazinderivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/28/1994 | EP0617024A1 Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof |
| 09/28/1994 | EP0617023A1 Benzimidazole derivatives, their preparation and use |
| 09/28/1994 | EP0617010A1 Therapeutic compounds |
| 09/28/1994 | EP0617006A1 N-subtituted derivatives of N-methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine and the procedure for their preparation |
| 09/28/1994 | EP0617001A1 Phenoxyphenylacetic acid derivatives |
| 09/28/1994 | EP0616813A2 Antitumor mitoxantrone polymeric compositions |
| 09/28/1994 | EP0616809A1 Intraocular irrigating and enucleated eyeball preservative composition |
| 09/28/1994 | EP0616808A1 Use of rifaximin and pharmaceutical compositions containing it in the treatment of gastric dyspepsia caused by helicobacter pylori |
| 09/28/1994 | EP0616807A1 Benzimidazole useful in the treatment of central nervous system disorders |
| 09/28/1994 | EP0616806A1 Phenylenediamine or benzimidazole derivatives for treating coccidiosis |
| 09/28/1994 | EP0616805A1 Use of acyl L-carnitine gamma-hydroxybutyrate for the treatment of alcoholism |
| 09/28/1994 | EP0616804A1 Gamma-hydroxybutyric acid salts possessing anxiolytic activity and suitable for the treatment of states of depression |
| 09/28/1994 | EP0616803A2 Method for enhancing T-cell count |
| 09/28/1994 | EP0616799A1 Cosmetic delivery system for salicylic acid and process for preparation of same |
| 09/28/1994 | EP0616537A1 CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS |
| 09/28/1994 | EP0616534A1 Blocking the effect of teratogens on a fetus |
| 09/28/1994 | EP0616533A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification |
| 09/28/1994 | EP0616532A1 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease |
| 09/28/1994 | EP0616531A1 1,4-dihydropyridines for use in the treatment of dermatosis |
| 09/28/1994 | EP0616530A1 Use of cytochalasins for inhibiting viral replication |
| 09/28/1994 | EP0616524A1 Medicaments |
| 09/28/1994 | EP0616523A1 Medicaments |
| 09/28/1994 | EP0616519A1 Oral compositions for suppressing mouth odors |
| 09/28/1994 | EP0616494A1 1- n-(halo-3-pyridylmethyl)]-n-methylamino-1-alkylamino-2-nitroethylene derivatives for use against fleas on pets |
| 09/28/1994 | EP0616493A1 Methods and compositions for reducing multi-drug resistance |
| 09/28/1994 | EP0539451B1 Vinylsulphonyl pristinamycin and preparation thereof |
| 09/28/1994 | EP0537267B1 Autobiotics and their use in eliminating nonself cells in vivo |
| 09/28/1994 | EP0507944B1 Implantable biodegradable material and method for producing same |
| 09/28/1994 | EP0440684B1 Novel s-timolol derivative and process for its preparation |
| 09/28/1994 | EP0340243B1 Cc-1065 analogs |
| 09/28/1994 | CN1092811A Novel thiomarinol derivatives, and processes for their preparation |
| 09/28/1994 | CN1092779A Compound using as targetable bone drug with estrogen structure |
| 09/28/1994 | CN1092776A 2-(9-fluorenonyl)-carbapenem intermediates |
| 09/28/1994 | CN1092775A Pharmaceuticals |
| 09/28/1994 | CN1092773A Novel antimicrobial 5-(N-heterosubstituted amino) quinolones |
| 09/28/1994 | CN1092772A Pharmaceuticals |
| 09/28/1994 | CN1092771A Aminomethylene substituted non-aromatic heterocycles |
| 09/28/1994 | CN1092768A Pyrazoles and pyrazolopyrimidines |
| 09/28/1994 | CN1092767A Spiro piperdines and homologs promote release of growth hormone |
| 09/28/1994 | CN1092766A Pharmaceuticals |
| 09/28/1994 | CN1092765A Novel tryptamine analogues and process for the preparation and the use thereof |
| 09/28/1994 | CN1092763A Preparation of beta-methyl carbapenem intermediates |
| 09/28/1994 | CN1092669A Natural skin-care raw material-Saussurea involucrata extract of alcohol |
| 09/28/1994 | CN1092654A Use of hyaluronic acid and forms to prevent arterial restenosis |
| 09/28/1994 | CN1092653A Veterinary antipyretic powder, injection and producing process thereof |
| 09/28/1994 | CN1092651A External compound corticoid preparation |
| 09/28/1994 | CN1092650A Pharmaceutical with novel imidazol-1-yl-link |
| 09/28/1994 | CN1092649A Controlled-release nifedipine tablet and processing method thereof |
| 09/28/1994 | CN1092648A Ranitidine compositions |
| 09/28/1994 | CN1026005C Antiplaque antibacterical oral composition |
| 09/28/1994 | CN1025999C ImidazoÛ4,5-BÙquinolinyloxyalkanoic acid amides with enhanced water solubility |
| 09/28/1994 | CN1025998C 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines |